# Diclofenac Dose Response Study

> **NCT06636227** · PHASE1 · RECRUITING · sponsor: **University of Maryland, Baltimore** · enrollment: 24 (estimated)

## Conditions studied

- Alcohol Use Disorder (AUD)
- Alcohol-Related Disorders

## Interventions

- **DRUG:** Diclofenac 100mg
- **DRUG:** Diclofenac 75mg
- **DRUG:** Diclofenac 50mg
- **DRUG:** Placebo control

## Key facts

- **NCT ID:** NCT06636227
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-01
- **Primary completion:** 2026-05-31
- **Final completion:** 2026-08-31
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06636227

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06636227, "Diclofenac Dose Response Study". Retrieved via AI Analytics 2026-08-08 from https://api.ai-analytics.org/clinical/NCT06636227. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*